NasdaqCM - Nasdaq Real Time Price • USD
HOOKIPA Pharma Inc. (HOOK)
As of 1:45 PM EDT. Market Open.
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 4 | 4 |
| Avg. Estimate | -0.1 | -0.05 | -0.36 | -0.51 |
| Low Estimate | -0.18 | -0.13 | -0.6 | -0.72 |
| High Estimate | -0.04 | 0.05 | -0.04 | -0.37 |
| Year Ago EPS | -0.27 | -0.22 | -0.86 | -0.36 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 3 | 3 |
| Avg. Estimate | 2.8M | 10.47M | 32.9M | 14.93M |
| Low Estimate | 2M | 2M | 8M | 7.89M |
| High Estimate | 4M | 25M | 72.5M | 25M |
| Year Ago Sales | 4.39M | 2.68M | 20.13M | 32.9M |
| Sales Growth (year/est) | -36.20% | 290.80% | 63.40% | -54.60% |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | -0.23 | -0.21 | -0.21 | -0.19 |
| EPS Actual | -0.27 | -0.22 | -0.17 | -0.22 |
| Difference | -0.04 | -0.01 | 0.04 | -0.03 |
| Surprise % | -17.40% | -4.80% | 19.00% | -15.80% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.1 | -0.05 | -0.36 | -0.51 |
| 7 Days Ago | -0.1 | -0.05 | -0.36 | -0.51 |
| 30 Days Ago | -0.11 | -0.08 | -0.39 | -0.58 |
| 60 Days Ago | -0.12 | -0.07 | -0.39 | -0.58 |
| 90 Days Ago | -0.22 | -0.23 | -0.72 | -0.88 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | 3 | 1 | 1 | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | HOOK | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 63.00% | -- | -- | 0.30% |
| Next Qtr. | 77.30% | -- | -- | 9.80% |
| Current Year | 58.10% | -- | -- | 4.50% |
| Next Year | -41.70% | -- | -- | 13.40% |
| Next 5 Years (per annum) | 14.50% | -- | -- | 11.06% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Reiterates | RBC Capital: Outperform to Outperform | 3/25/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/25/2024 |
| Maintains | RBC Capital: Outperform to Outperform | 1/30/2024 |
| Reiterates | RBC Capital: Outperform to Outperform | 9/27/2023 |
| Reiterates | Truist Securities: Buy to Buy | 9/6/2023 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 8/11/2023 |
Related Tickers
TSBX Turnstone Biologics Corp.
3.0050
-1.80%
TERN Terns Pharmaceuticals, Inc.
4.7900
+2.13%
XFOR X4 Pharmaceuticals, Inc.
1.2550
+2.03%
PASG Passage Bio, Inc.
1.2101
-1.62%
EFTR eFFECTOR Therapeutics, Inc.
1.8500
-4.64%
MIST Milestone Pharmaceuticals Inc.
1.6601
-2.35%
DTIL Precision BioSciences, Inc.
10.12
-1.09%
PDSB PDS Biotechnology Corporation
3.3000
+3.13%
ALGS Aligos Therapeutics, Inc.
0.8150
-1.04%
VINC Vincerx Pharma, Inc.
0.9199
-3.17%